1Department of Emergency Medicine and Indianapolis EMS, Indiana University School of Medicine, Indianapolis, IN;
2Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN;
3Department of Medicine, University of Mississippi School of Medicine, Jackson, MI; and
4Institute of Emergency for Cardiovascular Diseases “Prof C. C. Iliescu” Bucharest, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Address for correspondence: Associate Professor, Department of Emergency Medicine, Director, Clinical Research Indiana University School of Medicine, Faculty Office Building, 3rd Floor, Eskenazi Health 640, Eskenazi Avenue, Indianapolis, IN 46032. E-mail: email@example.com
O. Chioncel reports grants from Novartis, Servier and Vifor, outside the submitted work. S. P. Collins reports grants from NIH, PCORI, AHA, AHRQ, BMS, Novartis, personal fees from Novartis, Trevena, outside the submitted work. P. S. Pang reports grants, personal fees and non-financial support from Baxter, BMS, Roche, Trevena, Novartis, outside the submitted work; and is associate editor for JACC-HF, and on the editorial board for the Journal of Cardiac Failure; Research support from NIH/NHLBI, AHA, AHRQ, and PCORI, outside the submitted work. J. Butler reports other from Amgen, other from Array, other from Astra Zeneca, other from Bayer, other from Boehringer Ingelheim, other from Bristol Myers Squib, other from CVRx, other from G3 Pharmacautical, other from Innolife, other from Janssen, other from Luitpold, other from Medtronic, other from Merck, other from Novartis, other from Relypsa, other from StealthPeptide, other from SC Pharma, other from Vifor, other from ZS Pharma, outside the submitted work.